SCIENTIFIC PROGRAMME
SCIENTIFIC PROGRAMME
SCIENTIFIC PROGRAMME
RELATIONSHIP OF INDUCED SPUTUM MACROPHAGE COUNT AND AIRWAY HYPERRESPONSIVENESS IN CHRONIC ASTHMA
REPRODUCIBILITY OF AIRWAY WALL AREA MEASUREMENTS ON HRCT IN ASTHMA
CORTICOSTEROID INDUCED CHANGES IN AIRWAY INFLAMMATORY PARAMETERS IN EOSINOPHILIC BRONCHITIS WITH AND WITHOUT ASTHMA
THE RELATIONSHIP BETWEEN BACTERIAL LOAD AND NEUTROPHILIC BRONCHIAL INFLAMMATION IN STABLE COPD
SPUTUM EOSINOPHILIA AND THE RESPONSE TO PREDNISOLONE IN COPD
INHALED BACTERIAL LIPOSACCHARIDE RECRUITS AND ACTIVATES SPUTUM NEUTROPHILS IN HEALTHY HUMAN SUBJECTS
ROLE OF NASAL INTERMITTENT POSITIVE PRESSURE VENTILATION (NIPPV) IN CYSTIC FIBROSIS PATIENTS
DETECTION OF IgA AND IgG ANTIBODIES TO BURKHOLDERIA CEPACIA IN INTERMITTENTLY OR CHRONICALLY COLONSISED ADULT CYSTIC FIBROSIS (CF) PATIENTS
THE PREVALENCE OF CEFTAZIDIME RESISTANT PSEUDOMONAS AERUGINOSA (Pa) STRAINS IN AN ADULT CF CLINIC
THE RELATIONSHIP OF OUTCOME TO BURKHOLDERIA CEPACIA, LUNG FUNCTION AND INFLAMMATORY MARKERS IN STABLE PATIENTS WITH CYSTIC FIBROSIS
PHASE II TRIAL TO ASSESS THE BIOCHEMICAL EFFICACY OF TRANSGENIC ALPHA1-ANTI-TRYPSIN AS AN EFFECTIVE TREATMENT OF CYSTIC FIBROSIS
INTRAMUSCULAR GENE TRANSFER OF INTERLEUKIN-10 cDNA: TOWARDS TREATMENT FOR LUNG INFLAMMATION.
RESULTS OF A TWO YEAR LUNG VOLUME REDUCTION SURGERY PROGRAMME IN THE MERSEY REGION
CHANGES IN QUALITY OF LIFE FOLLOWING LUNG VOLUME REDUCTION SURGERY
LUNG VOLUME REDUCTION SURGERY IN PULMONARY EMPHYSEMA; RESULTS OF A RANDOMISED, CONTROLLED TRIAL.
LUNG VOLUME REDUCTION SURGERY; BILATERAL OR UNILATERAL PROCEDURE?
DOES THE RADIOGRAPHIC EXTENT OF DISEASE IN PULMONARY TUBERCULOSIS INFLUENCE THE TWO MONTH SMEAR CONVERSION RATE?
IDENTIFYING PRIORITIES FOR THE TUBERCULOSIS (TB) SERVICE IN NEWHAM, EAST LONDON
IS CURRENT UK PRACTICE OF ROUTINELY SCREENING CONTACTS OF ALL SPUTUM "SMEAR POSITIVE" PATIENTS EFFICIENT?
1998 NATIONAL TB SURVEY IN ENGLAND & WALES: FINAL RESULTS
TUBERCULOSIS AND HIV/AIDS CO-INFECTION IN ENGLAND & WALES IN 1998
MORTALITY ASSOCIATED WITH A PREVIOUS DIAGNOSIS OF TUBERCULOSIS IN LIVERPOOL
RISK FACTORS FOR PERSISTENCE AND EMERGENCE OF WHEEZING ILLNESS IN THE TRANSITION FROM CHILDHOOD TO EARLY ADULTHOOD
CORTICOSTEROID INSENSITIVE ASTHMA IN CHILDREN
DIET AND CHILDHOOD ASTHMA IN SAUDI ARABIA
INTERLEUKIN-4 SOLUBLE RECEPTOR α IS INCREASED IN THE AIRWAYS OF ASTHMATIC CHILDREN COMPARED TO NON ASTHMATICS
WHEEZING IN INFANTS WITH AN ATOPIC TENDENCY RESPONDS TO INHALED FLUTICASONE
Chest X-rays in Acute Paediatric Asthma
PROTEIN STRUCTURAL TRANSITIONS IN CHRONIC AIRFLOW OBSTRUCTION: INSIGHTS FROM THE CHARACTERISATION AND 2.5Å CRYSTAL STRUCTURE OF A PATHOGENIC FORM OF ALPHA1-ANTICHYMOTRYPSIN
Characterization of Promoter activity of the 5′ Untranslated Regions of CXCR1 and CXCR2 in a Human Myeloid Cell Line
TWO DISTINCT SMOOTH MUSCLE SUBPOPULATIONS ISOLATED FROM THE HUMAN AIRWAY DIFFER IN ENDOTHELIN RECEPTOR EXPRESSION AND ADRENOMEDULLIN RELEASE
INHIBITION BY β2-ADRENOCEPTOR AGONISTS AND DEXAMETHASONE ON TNFα STIMULATED EOTAXIN RELEASE FROM HUMAN AIRWAY SMOOTH MUSCLE CELLS
SIMULTANEOUS DETERMINTION OF THE GLUTATHIONE S-TRANSFERASE, GSTP1, A114V AND I105V ALLELES USING ARMA-PCR: STUDIES IN PATIENTS WITH ASTHMA
LATENT ADENOVIRAL INFECTION RENDERS ALVEOLAR EPITHELIAL CELLS SUSCEPTIBLE TO PARTICLE INDUCED TRANSCRIPTION OF PRO-INFLAMMATORY MEDIATORS
REDUCING WAITING TIMES FOR SAHS: USE OF A QUESTIONNAIRE AND HOME OXIMETRY.
PERFORMANCE OF PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA (OSA) ON A STEERING SIMULATION AFTER SIX MONTHS TREATMENT WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE (NCPAP)
SLEEP APNOEA IN PATIENTS FOLLOWING STROKE
CASE CONTROL STUDY OF MAGNETIC RESONANCE IMAGE DEFINED SUBCLINICAL CEREBROVASCULAR DAMAGE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA AND NORMAL CONTROL SUBJECTS
PERSISTENCE OF EXCESSIVE DAYTIME SLEEPINESS AFTER TREATMENT WITH nCPAP FOR OSA
THE INCIDENCE OF UPPER AIRWAY OBSTRUCTION IN ACUTE STROKE
CPAP-TREATMENT FOR SAHS: PREDICTORS OF ACCEPTANCE AND LONG TERM USE
EFFECT OF REGULAR INTERMITTENT NONINVASIVE POSITIVE PRESSURE VENTILATION IN STABLE HYPERCAPNIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
A COST-EFFECTIVENESS ANALYSIS OF NON-INVASIVE VENTILATION (NIV) IN ACUTE EXACERBATIONS OF COPD.
LONGTERM SURVIVAL FOLLOWING AN EXACERBATION OF COPD TREATED WITH AND WITHOUT NON-INVASIVE VENTILATION.
NON INVASIVE POSITIVE PRESSURE VENTILATION (NIPPV) IN ACUTE RESPIRATORY FAILURE - DOES IT MATTER WHO INITIATES AND SUPERVISES IT?
NON-INVASIVE VENTILATION OF COPD IN A HIGH DEPENDENCY UNIT: EXPERIENCE AND PREDICTORS OF OUTCOME
FUNCTIONAL IMPORTANCE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AS A MEDIATOR OF VASCULAR PERMEABILITY IN ARDS.
EVIDENCE THAT G-CSF PLAYS AN IMPORTANT ROLE IN MECHANISMS OF PULMONARY NEUTROPHILIA IN ARDS
A ROLE FOR ACUTE HYPOXIA / HYPEROXIA IN THE PATHOGENESIS OF THE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) - AN IN VIVO MODEL
ADENOVIRUS-MEDIATED TRANSFER OF ELAFIN cDNA ENHANCES NEUTROPHIL MIGRATION AND PROTECTS AGAINST NEUTROPHIL-MEDIATED INJURY
THE CLEARANCE OF MACROPHAGES DURING THE RESOLUTION OF ACUTE PERITONEAL INFLAMMATION IS ENHANCED BY LIPOPOLYSACCHARIDE (LPS) BUT RETARDED BY METHYLPREDNISOLONE (MTP)
TRANSFERRIN RECEPTORS AND FERRITIN PROTEIN LEVELS IN HEART AND LUNG FOLLOWING LPS TREATMENT
IMMEDIATE VERSUS DELAYED THORACIC RADIOTHERAPY (TRT) IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND MINIMAL SYMPTOMS: RESULTS OF AN MRC/BTS RANDOMISED TRIAL
A NATIONAL SURVEY OF CHEMOTHERAPY (CT) IN SMALL CELL LUNG CANCER (SCLC)
LUNG FUNCTION AND SURGERY FOR LUNG CANCER - IMPLICATIONS OF THE BTS RECOMMENDATIONS FOR FITNESS FOR SURGERY
RCP LUNG CANCER AUDIT - FACTORS ASSOCIATED WITH POOR 6 MONTH SURVIVAL IN NON-SMALL CELL CANCER
SELECTION OF PATIENTS FOR LUNG CANCER RESECTION - ARE THE BTS GUIDELINES MISLEADING?
IL-4 PROMOTER POLYMORPHISM IS ASSOCIATED WITH DEVELOPMENT OF CRYPTOGENIC FIBROSING ALVEOLITIS AND SYSTEMIC SCLEROSIS BUT NOT SARCOIDOSIS.
HEALTH RELATED QUALITY OF LIFE (HRQoL) AND LUNG FUNCTION IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS (CFA)
THE RAPAMYCIN ANALOGUE SDZ RAD ATTENUATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS
UP-REGULATION OF IGFBP-rP2 (CTGF) PROTEIN IN PULMONARY SARCOIDOSIS AND IDIOPATHIC PULMONARY FIBROSIS PATIENTS
DIRECT THROMBIN INHIBITION ATTENUATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS
A RANDOMISED CONTROLLED TRIAL OF FOUR WEEKS V SEVEN WEEKS PULMONARY REHABILITATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
DO THE EFFECTS OF PULMONARY REHABILITATION (PR) LAST FOR 1 YEAR IN PATIENTS WITH COPD?
IMPROVEMENTS IN DOMESTIC FUNCTION AFTER PULMONARY REHABILITATION
OUTCOMES OF A PULMONARY REHABILITATION PROGRAMME FOLLOWING ACUTE ADMISSION WITH COPD
THE MANAGEMENT OF LUNG CANCER IN SCOTLAND - THE 1995 REALITY
Worrying respiratory symptoms in an urban population
DO CALMAN/HINE LUNG CANCER MULTIDISCIPLINARY MEETINGS (MDM) ACHIEVE THEIR GOALS REGARDING SURGERY?
LUNG CANCER CARE: A COMPARISON WITH BREAST CANCER
DELAYS IN LUNG CANCER TREATMENT AFTER BRONCHOSCOPY
EVALUATION OF A NURSE LED FAST TRACK ASSESSMENT CLINIC FOR BRONCHOSCOPY
GAMMA CAMERA POSITRON EMISSION TOMOGRAPHY (GCP) STAGING OF PATIENTS WITH POTENTIALLY OPERABLE NON-SMALL CELL LUNG CANCER (NSCLC)
EARLY EXPERIENCE WITH THE DIODE LASER IN TRACHEOBRONCHIAL TUMOUR RESECTION
THE SIGNIFICANCE OF N2 NODE INVOLVEMENT AT THORACOTOMY IN NON-SMALL CELL LUNG CANCER
SERUM P53 ANTIBODIES IN SMALL-CELL LUNG CANCER
HISTOLOGICAL DIAGNOSIS OF LUNG CANCER
SURGICAL RESECTION RATE AND OUTCOME IN A SERIES OF CONSECUTIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER
SURGERY FOR PULMONARY METASTATECTOMY: EARLY RESULTS AND PROGNOSTIC FACTORS
INCREASED PLATELET AND MICROVESSEL COUNTS CONFER POOR PROGNOSIS IN OPERABLE NON-SMALL CELL LUNG CANCER
THE INDETERMINATE SOLITARY PULMONARY NODULE - THE BENEFITS OF AN AGGRESSIVE SURGICAL APPROACH
LOCAL ANTIBIOTIC GUIDELINES FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP): A SURVEY OF UK PRACTICE IN 1999
Are junior doctors confident about antibiotic prescribing for adults with Lower Respiratory Tract Illness (LRTi)?
Do results of initial investigations correlate with final diagnosis in Lower Respiratory Tract Illness (LRTi)?
DIRECT AND INDIRECT EVIDENCE OF INFECTION IN PREVIOUSLY WELL ADULTS CONSULTING WITH LOWER RESPIRATORY TRACT ILLNESS (LRTi): A PROSPECTIVE STUDY IN PRIMARY CARE
ASSESSING THE INCIDENCE OF LOWER RESPIRATORY TRACT ILLNESS (LRTi) IN PREVIOUSLY WELL ADULTS CONSULTING IN PRIMARY CARE
Prospective study of the outcome of adult lower respiratory tract illness (LRTi) in the community and the relationship to aetiology and management
AN ASSESSMENT, BY PATIENT QUESTIONNAIRE, OF THE USE OF ZANAMIVIR AND ITS DELIVERY DEVICE IN THE TREATMENT OF INFLUENZA
ZANAMIVIR STUDIES IN THE TREATMENT OF INFLUENZA: AN ANALYSIS OF POOLED EFFICACY DATA
PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA(CAP)
RESPIRATORY RATE (RR); AN IMPORTANT SEVERITY SIGN. HOW VARIABLE IS THE MEASUREMENT IN ADULTS?
HOSPITAL MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN NORFOLK - AN AUDIT OF COMPLIANCE WITH ERS GUIDELINES
CONTINUED UTILITY OF BRONCHOSCOPY IN AN HIV INFECTED POPULATION
THE EPIDEMIOLOGY OF FAMILIAL SARCOIDOSIS IN THE UK
HLA-DR ALLELES ASSOCIATED WITH DISEASE IN CZECH AND POLISH PULMONARY SARCOIDOSIS PATIENTS
A CROSS-SECTIONAL SURVEY OF NOCTURNAL HYPOXAEMIA IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS (CFA).
DOES EATING FISH AND FRESH VEGETABLE PROTECT AGAINST THE RISK OF DYING FROM CRYPTOGENIC FIBROSING ALVEOLITIS (CFA)?
DISTRIBUTION OF NOVEL POLYMORPHISMS OF THE IL-8 AND IL8 RECEPTOR A AND B GENES IN FIBROSING ALVEOLITIS.
BODY MASS INDEX IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITIS
CELL WALL-DEFICIENT MYCOBACTERIA IN THE BLOOD OF PATIENTS WITH SARCOIDOSIS
WHICH SYMPTOMS AND IMMUNOLOGICAL DATA PREDICT LOSS OF EMPLOYMENT IN WORKERS EXPOSED TO GRAIN? CHARATERISTICS OF A SURVIVOR POPULATION
DUST MITE ALLERGENS ARE NOT CARRIED ONLY ON LARGE PARTICLES
ASTHMA ADMISSIONS, THUNDERSTORMS, POLLEN, FUNGAL SPORES AND OZONE CONCENTRATIONS
MEASUREMENT OF T-HELPER CYTOKINES SECRETED BY CORD BLOOD MONONUCLEAR CELLS (CBMC) IN RESPONSE TO ALLERGENS
ACUTE HEALTH EFFECTS OF ULTRAFINE PARTICLES
HOUSE DUST MITE ALLERGEN LEVELS IN UNIVERSITY STUDENT ACCOMMODATION IN DUNEDIN, NEW ZEALAND
A NEW OUTBREAK OF ASTHMA AMONG DETERGENT POWDER MANUFACTURERS
CROSS SHIFT CHANGES IN EXHALED NITRIC OXIDE LEVELS IN WORKERS AT RISK OF EXPOSURE TO RESPIRATORY SENSITISERS
SYNTHETIC PILLOWS CONTAIN HIGHER LEVELS OF CAT AND DOG ALLERGEN THAN FEATHER PILLOWS
A STUDY TO DETERMINE THE EFFICACY OF A TOLERISING RYEGRASS PEPTIDE, PTL-0901, IN THE TREATMENT OF SEASONAL HAYFEVER
OCCUPATIONAL ASTHMA DUE TO AMYLASE USED IN DETERGENTS
IMPACT OF MITE ERADICATION IN HOMES ON BRONCHIAL HYPERRESPONSIVENESS OF ADULT ASTHMATICS
ULTRAFINE PARTICLES MEDIATES IL-8 PRODUCTION VIA A NF-κB MECHANISM
THE EFFECT OF HOME RENOVATION ON HEALTH-RELATED ENVIRONMENTAL PARAMETERS
CHANGES IN ASTHMA SYMPTOMS AND AIRWAY RESPONSIVENESS OVER A SIX YEAR PERIOD AMONGST NEWCASTLE RESIDENTS
INDOOR SOURCES OF ULTRAFINE PARTICLES
MEASUREMENT OF INSPIRATION FLOW TO ASSESS THE INHALATION TECHNIQUE OF CHRONIC OBSTRUCTIVE AIRWAY DISEASE (COPD) PATIENTS USING A DRY POWDER INHALER (DPI)
DOSE RESPONSE FOR ADRENAL SUPPRESSION WITH HFA AND CFC FORMULATIONS OF FLUTICASONE PROPIONATE
COMPARISON OF THE AIRWAY AND SYSTEMIC EFFECTS OF INHALED TERBUTALINE ADMINISTERED BY FOUR DIFFERENT DELIVERY DEVICES
PROTECTION AGAINST METHACHOLINE CHALLENGE: A METHOD OF ESTABLISHING THE DOSE-RESPONSE RELATIONSHIP OF SALBUTAMOL DELIVERED VIA DRY POWDER INHALER (DPI) AND METERED DOSE INHALER (MDI)
COMPARISON OF THE MOMETASONE FUROATE DRY POWDER INHALER (MF DPI) WITH TURBOHALER® USING A NEW METHODOLOGY FOR AN IN VITRO ANALYSIS OF INHALER PERFORMANCE
EFFICACY AND SAFETY OF THREE DAILY DOSE LEVELS OF MOMETASONE FUROATE DRY POWDER INHALER (MF DPI) IN THE TREATMENT OF ASTHMATICS REQUIRING HIGH DOSE INHALED CORTICOSTEROIDS
COMPARISON OF THE RELATIVE POTENCIES OF FLUTICASONE PROPIONATE AND BUDESONIDE UPON BRONCHIAL HYPERRESPONSIVENESS AND HPA AXIS FUNCTION IN ASTHMATIC PATIENTS
DO NATIONAL GUIDELINES WORK? LESSONS FROM SPONTANEOUS PNEUMOTHORAX
THE INCORPORATION OF HELICAL COMPUTED TOMOGRAPHIC PULMONARY ANGIOGRAPHY (CTPA) INTO AN IMAGING ALGORITHM FOR INVESTIGATING ACUTE PULMONARY EMBOLISM
Pneumothorax: A Survey of Junior Doctors
THE RISK OF CEREBRAL HAEMORRHAGE IN FAMILIES WITH HHT AND PULMONARY AVMS
COMPLIANCE WITH PNEUMOTHORAX GUIDELINES; A REGIONAL SURVEY
RETROSPECTIVE AUDIT OF PULMONARY EMBOLISM IN A DISTRICT GENERAL HOSPITAL
PRE-TEST PROBABILITY AND D DIMER TESTING FOR EXCLUDING PULMONARY EMBOLUS
ARDS FOLLOWING LOBECTOMY: A UNILATERAL PHENOMENON?
OPTIMISATION OF MEDICAL PATIENTS PRIOR TO TRANSFER TO THE INTENSIVE CARE UNIT: A RETROSPECTIVE STUDY.
MANAGEMENT OF SPONTANEOUS PNEUMOTHORAX AT TWO MAJOR HOSPITALS IN SOUTH WALES
A "ONE STOP" CT/BRONCHOSCOPY CLINIC FOR PATIENTS WITH SUSPECTED LUNG CANCER: A DISTRICT GENERAL HOSPITAL EXPERIENCE
LUNG CANCER IN SCOTLAND - IMPORTANCE OF SEEING A CHEST PHYSICIAN
Effects of diagnostic process on quality of life (QOL) in patients with lung cancer.
HOW LONG DO PATIENTS WITH LUNG CANCER HAVE SYMPTOMS BEFORE PRESENTING TO HOSPITAL?
COSTS OF THE DIFFERENT PHASES OF MANAGING SMALL CELL LUNG CANCER
CLINICAL TRIALS IN LUNG CANCER: CAN A PROGRAMMED INVESTIGATION UNIT AND A MULTIDISCIPLINARY CLINIC HELP?
PATIENTS' PREFERENCE OR PROFESSIONALS' PERSPECTIVE - FOLLOW-UP PREFERENCES AT A MULTIDISCIPLINARY LUNG ONCOLOGY CLINIC (MLOC)
MULTIPROFESSIONAL MEETINGS (MPM) FOR LUNG CANCER MANAGEMENT: AN AUDIT OF DECISIONS
PATIENT PERCEPTIONS OF A LUNG CANCER SERVICE
RADIOLOGIST ERROR AS A FACTOR IN DELAYS IN THE DIAGNOSIS OF LUNG CANCER
TELEMEDICINE FOR LUNG CANCER: A NEW MULTIDISCIPLINARY APPROACH
IMPROVED SURGICAL RESECTION RATES AS A RESULT OF CHANGES IN ORGANISATION OF LUNG CANCER SERVICES
TESTOSTERONE INDUCED PULMONARY ARTERIAL VASODILATION IS NON-GENOMIC AND FLUTAMIDE, NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE INSENSITIVE
PULMONARY ARTERIAL VASODILATORY ACTION OF 17β OESTRADIOL, PROGESTERONE & TESTOSTERONE
PHOSPHODIESTERASE ISOENZYME EXPRESSION IN RAT PULMONARY ARTERY SMOOTH MUSCLE CELLS AND THE EFFECT OF PHOSPHODIESTERASE INHIBITION ON CELLULAR PROLIFERATION
PULMONARY ARTERY SMOOTH MUSCLE CELLS FROM PATIENTS WITH PRIMARY PULMONARY HYPERTENSION EXHIBIT ENHANCED GROWTH RESPONSES TO IGF-1 AND bFGF
BLOCKING K+ CHANNELS INHIBITS SERUM STIMULATED FIBROBLAST PROLIFERATION AND p38 MAP KINASE ACTIVITY IN PULMONARY ARTERY CELLS FROM CHRONICALLY HYPOXIC RATS.
PROLIFERATION AND APOPTOSIS IN CULTURED PULMONARY ARTERIAL AND AORTIC ADVENTITIAL FIBROBLASTS FROM CHRONICALLY HYPOXIC RATS
SHUTTLE WALK TEST, PULMONARY ARTERY PRESSURE (PA), AND PO2 MEASUREMENTS IN PRIMARY PULMONARY HYPERTENSION (PPH)
THE RELATIONSHIP BETWEEN PULMONARY ARTERY PRESSURE AND EXHALED NITRIC OXIDE IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS.
PREVALENCE OF PULMONARY HYPERTENSION IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS
ANTI-ET-1 OLIGONUCLEOTIDES AS A POTENTIAL TREATMENT FOR PULMONARY HYPERTENSION.
CHRONIC DEXFENFLURAMINE TREATMENT REDUCES THE LEVELS OF SEROTONIN TRANSPORTER mRNA IN NORMOXIC AND CHRONICALLY HYPOXIC WISTAR AND FAWN HOODED RATS.
PULMONARY VASOACTIVITY OF FENFLURAMINES AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS, FLUOXETINE AND AMITRIPTYLINE, IN THE RAT
PULMONARY VASOREACTIVITY OF RADIOCONTRAST MEDIA IN PULMONARY HYPERTENSION - RAT MODEL
INHALATION OF ENDOTHELINA/B RECEPTOR ANTAGONIST PARTIALLY REVERSES CHRONIC HYPOXIC PULMONARY HYPERTENSION IN THE RAT
PROGRESSION IN HAEMODYNAMICS AND OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY HYPERTENSION.
Fibrotic & non fibrotic pulmonary hypertension in systemic sclerosis: differences in haemodynamics and outcome.
CYCLOOXYGENASE-2 INDUCTION REPRESENTS AN ENDOGENOUS 'BRAKE' ON ET-1 PRODUCTION BY HUMAN PULMONARY ARTERY SMOOTH MUSCLE
CICAPROST, A STABLE PROSTACYCLIN ANALOGUE, INHIBITS ENDOGENOUS ENDOTHELIN-1 RELEASE IN HUMAN PULMONARY ARTERY SMOOTH MUSCLE CELLS
CLINICAL FEATURES AND OUTCOMES OF ACUTE HYPERCAPNIC RESPIRATORY FAILURE IN A DISTRICT GENERAL HOSPITAL
PRESCRIBING OF INHALED STEROIDS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, EXPERIENCE IN A DISTRICT GENERAL HOSPITAL
DECISION MAKING IN THE PROVISION OF HOME NEBULISED THERAPY FOR PATIENTS WITH CHRONIC AIRFLOW LIMITATION
THE USE OF DOMICILIARY NEBULISERS BY COPD PATIENTS IN LIVERPOOL
CHARACTERISTICS OF 25 PATIENTS IN THE HOSPITAL AT HOME SERVICE COMPARED TO A HISTORICAL COHORT 246 PATIENTS HOSPITALISED WITH EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
HOME OR SURGERY BASED SCREENING FOR COPD?
THE HISTORY, PRESENTATION AND UTILISATION OF RESOURCE IN PRIMARY CARE PATIENTS WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
MAKING SPIROMETRY HAPPEN
RAPID ACCESS SPIROMETRY AND REVERSIBILITY TESTING FOR COPD PATIENTS IN THE COMMUNITY
EARLY SUPPORTED DISCHARGE AS AN ALTERNATIVE TO LONG STAY HOSPITAL ADMISSION IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
HOSPITAL AT HOME FOR EXACERBATIONS OF COPD - A FEASIBILITY STUDY
BRITISH LUNG FOUNDATION SURVEY OF RESPIRATORY HEALTH CARE PROVISION IN GREATER LONDON
Relationship between urinary cotinine concentration in mothers and their asthmatic offspring.
The safety of nebulised fluticasone propionate (FP) 1 mg twice daily compared with soluble prednisolone for 7 days given to 4 - 16 year old children with asthma.
REGULAR INHALED SALBUTAMOL FOR WHEEZY INFANTS: A RANDOMISED CONTROLLED TRIAL
EXHALED NITRIC OXIDE IS DECREASED IN INFANTS WITH CYSTIC FIBROSIS.
WHICH ARE THE APPROPRIATE TIMED FORCED EXPIRATORY VOLUME PARAMETERS IN YOUNG INFANTS?
DO ORAL CORTICOSTEROIDS CAUSE SPUTUM NEUTROPHILIA IN CHILDREN WITH SEVERE ASTHMA?
LUNG FUNCTION IN SURVIVORS OF CHILDHOOD LEUKAEMIA- A FOLLOW-UP STUDY
ASTHMA SEVERITY AND ANXIETY LEVELS IN SECONDARY SCHOOLCHILDREN
RESPONSES TO A SLEEP QUESTIONNAIRE IN 300 INDIANS ATTENDING ROUTINE HEALTH SCREENING
CASE CONTROL STUDY OF 24-HOUR AMBULATORY BLOOD PRESSURE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA AND NORMAL MATCHED CONTROL SUBJECTS
THE GENETICS OF SNORING.
OFFERING CPAP TO ALL PATIENTS REFERRED FOR SNORING AND POSSIBLE SLEEP APNOEA:-AN ANALYSIS
THE USE OF AUTO-CPAP IN LONG TERM USERS OF FIXED PRESSURE CPAP
NARCOLEPSY PRESENTATIONS AND QUALITY OF LIFE
THE MEASURING OF EEG DURING A MONOTONOUS VIGILANCE TASK
MAMMARY TUBERCULOSIS IN A HIGH TB PREVALENCE AREA: A 20 YEAR REVIEW
AN INVESTIGATION OF THE PREVALENCE OF TUBERCULIN POSITIVE REACTORS AMONGST HEALTHY SUBJECTS IN CHESHIRE
TIME BETWEEN ONSET OF SYMPTOMS, PRESENTATION, START OF TREATMENT AND NOTIFICATION IN TUBERCULOSIS
TUBERCULOSIS TREATMENT OUTCOME MONITORING: BLACKBURN 1988-1997 INCLUSIVE
AN AUDIT OF TB NURSING/SECRETARIAL PROVISION IN HIGH INCIDENCE TB DISTRICTS IN ENGLAND AND WALES
ARE THERE STILL EFFECTS ON INDIAN SUBCONTINENT (ISC) TUBERCULOSIS OF RETURN VISITS?: A LONGITUDINAL STUDY 1978-97
EFFECT OF PERCUTANEOUS NEONATAL BCG VACCINATION ON SCREENING OF CHILD TUBERCULOSIS CONTACTS
TUBERCULOSIS PREVENTION AMONGST PRISON STAFF - ARE BTS RECOMMENDATIONS IMPLEMENTED?
SETTING STANDARDS FOR DIAGNOSING AND TREATING TUBERCULOSIS.
MEASUREMENT OF IgM, IgG AND IgA ANTIBODIES TO THE A60 ANTIGEN OF MYCOBACTERIUM TUBERCULOSIS
HIV SEROPREVALENCE BY ANONYMOUS TESTING IN PATIENTS WITH MYCOBACTERIUM TUBERCULOSIS AND TUBERCULOSIS CONTACTS
A SURVEY OF TUBERCULOSIS MANAGEMENT POLICIES IN UK RENAL UNITS
PROGRESS IN THE IMPLEMENTATION OF ENHANCED TUBERCULOSIS SURVEILLANCE IN ENGLAND & WALES
SOCIOECONOMIC DISADVANTAGE AND EMERGENCY TREATMENT FOR ASTHMA.
THE OCCURRENCE AND MANAGEMENT OF ACUTE ASTHMA IN SUFFOLK SCHOOLS
AN ASSESSMENT OF THE SUFFOLK SCHOOLS ASTHMA POLICY FOLLOWING IMPLEMENTATION; HAS IT MADE A DIFFERENCE?
THE GOALS OF PEOPLE WITH ASTHMA
PRESCRIBING PATTERNS OF ASTHMATIC CHILDREN IN PRIMARY CARE
PRESCRIBING PATTERNS OF ASTHMATIC ADULTS IN PRIMARY CARE
REDUCING ASTHMA READMISSIONS: IMPACT OF EARLY FOLLOW-UP BY RESPIRATORY CONSULTANT OR RESPIRATORY SPECIALIST NURSE
ACCURACY OF HOSPITAL DISCHARGE CODING IN ASTHMA AND COPD: IMPLICATIONS FOR MEASURING PERFORMANCE OF RAPID RESPONSE TEAMS
ANALYSIS OF THE IMPACT OF PRACTICE CHARACTERISTICS AND SOCIAL DEPRIVATION ON PRESCRIBING QUALITY FOR ASTHMA
FAMILIAL RISK OF AIRFLOW OBSTRUCTION AND EMPHYSEMA
WHAT PROTOCOL FOR CLINICAL EXERCISE TESTING: RAMP VERSUS ONE MINUTE STEP INCREMENTS?
ECHOCARDIOGRAPHIC ASSESSMENT OF PULMONARY HYPERTENSION SECONDARY TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
ACTIVITY LEVELS IN COPD ARE RELATED TO FATIGUE AND GENERAL HEALTH STATUS BUT NOT TO LUNG FUNCTION.
DETECTION OF NUTRITIONAL DEPLETION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A COMPARISON OF METHODS
VALIDATION OF A NEW SHORT HEALTH STATUS QUESTIONNAIRE FOR ROUTINE USE IN COPD
MOVEMENT DETECTORS TO MEASURE DAILY PHYSICAL ACTIVITY IN COPD
CURRENT MANAGEMENT OF A-1 ANTI-TRYPSIN DEFICIENCY: NEED FOR STANDARDISATION OF APPROACH
PREDICTING HEALTH IMPACTS IN COPD
LOWER BONE DENSITY IN COPD AND ASTHMA: INFLUENCE OF ONE STOP DEXA SCANNING
ACUTE ON CHRONIC RESPIRATORY FAILURE: DELETERIOUS EFFECTS OF HIGH FLOW OXYGEN THERAPY
POSSIBLE DIETARY DETERMINANTS OF OSTEOPOROSIS IN PATIENTS WITH CHRONIC AIRFLOW LIMITATION.
ELEVATED SPUTUM AMINO ACID CONCENTRATIONS AND AUXOTROPHY IN SEVERE CYSTIC FIBROSIS LUNG DISEASE
EXHALED BREATH CARBON MONOXIDE LEVELS ARE ELEVATED IN INFECTIVE EXACERBATIONS OF CYSTIC FIBROSIS AND FALL IN RESPONSE TO TREATMENT
COMPARISON OF MEDIATOR CONCENTRATIONS IN BAL AND INDUCED SPUTUM FROM PATIENTS WITH CYSTIC FIBROSIS, MILD ASTHMA AND HEALTHY VOLUNTEERS.
ASSESSEMENT OF NON-INVASIVE MARKERS OF INFLAMMATION IN CYSTIC FIBROSIS
Developing anti-inflammatory lung gene therapy
The use of carbon - 14 labelled bicarbonate to measure total energy expenditure in patients with cystic fibrosis
NASAL POTENTIAL DIFFERENCE RESPONSES TO VARYING TONICITY ARE ALTERED IN CYSTIC FIBROSIS.
A HIGH THROUGHPUT SCREEN FOR PROMOTERS OF CFTR TRAFFICKING
ACTIVATION OF A p50-CONTAINING NFκB COMPLEX IN CF MODELS.
A STUDY TO INVESTIGATE THE RENAL HANDLING OF ELECTROLYTES IN CYSTIC FIBROSIS.
INDICATIONS FOR ADMISSION OF CYSTIC FIBROSIS PATIENTS TO INTENSIVE CARE AND MORTALITY
OUTCOMES POST PULMONARY REHABILITATION WHEN COPD PATIENTS ARE CATEGORISED INTO MEDICAL RESEARCH (MRC) DYSPNOEA SCALE GRADES 3, 4 & 5
DOMICILIARY NON INVASIVE POSITIVE PRESSURE VENTILATION IN A SINGLE HEALTH DISTRICT.
DIFFERENCES IN CLINICAL OUTCOME WITH PRESSURE PRESET VENTILATORS IN CHRONIC RESPIRATORY FAILURE
THE EFFECT OF NON INVASIVE POSITIVE PRESSURE VENTILATION DURING EXERCISE IN SEVERE SCOLIOSIS
INCREASED EXERCISE CAPACITY IN PATIENTS WITH SEVERE COPD AFTER CYCLE TRAINING WITH PROPORTIONAL ASSIST VENTILATION (PAV)
PHYSIOLOGICAL TRAINING IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS POSSIBLE USING PROPORTIONAL ASSIST VENTILATION (PAV)
THE ROLE OF PRACTICE NURSES IN ACHIEVING GOVERNMENT SMOKING CESSATION TARGETS
Effects on exercise tolerance of the addition of domiciliary Non-invasive Positive Pressure Ventilation to physical training in severe COPD.
HEALTH ECONOMIC GAINS FROM PULMONARY REHABILITATION (PR) IN A DISTRICT GENERAL HOSPITAL SETTING
LEVELS OF BREATHLESSNESS DURING DOMESTIC ACTIVITY AND EXERCISE TRAINING IN CHRONIC LUNG DISEASE
THE IMMEDIATE EFFECT OF AUDITORY STIMULUS ON TREADMILL ENDURANCE WALKING
A PILOT STUDY OF SHORT PULMONARY REHABILITATION IN GENERAL PRACTICE
BODY COMPOSITION IN PATIENTS UNDERGOING A RANDOMISED CONTROLLED TRIAL OF PULMONARY REHABILITATION
PULMONARY TRANSPLANTATION IN CYSTIC FIBROSIS (CF): SECOND ORGAN DYSFUNCTION AT 3 YEARS POST TRANSPLANTATION
PULMONARY TRANSPLANTATION FOR CYSTIC FIBROSIS (CF): THE NEWCASTLE EXPERIENCE OVER 10 YEARS
THE EFFECT OF DONOR LUNG INFLAMMATION ON OUTCOME FOLLOWING HUMAN LUNG TRANSPLANTATION.
RISK FACTORS FOR THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME FOLLOWING LUNG AND HEART-LUNG TRANSPLANTATION
TACROLIMUS RESCUE THERAPY FOR BRONCHIOLITIS OBLITERANS SYNDROME FOLLOWING LUNG AND HEART-LUNG TRANSPLANTATION
A COMPARISON OF SPIROMETRIC INDICES AS EARLY MARKERS OF BRONCHIOLITIS OBLITERANS SYNDROME FOLLOWING LUNG AND HEART-LUNG TRANSPLANTATION
MYCOBACTERIAL DISEASE IN LUNG AND HEART-LUNG TRANSPLANT RECIPIENTS
A SYSTEMATIC REVIEW OF BECLOMETHASONE AND BUDESONIDE IN CHRONIC ASTHMA: LIMITED EVIDENCE FOR A DOSE RESPONSE EFFECT
A PLACEBO CONTROLLED COMPARISON OF THE EFFECT OF SINGLE DOSES OF SALMETEROL AND THE COMBINATION BRONCHODILATOR COMBIVENT ON LUNG FUNCTION OVER 12 HOURS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
APPARENT EFFICACY OF LONG ACTING BETA2-AGONISTS IN ASTHMA DEPENDS ON THE PHYSIOLOGICAL MEASURE USED
EFFECTS OF ADDING IN A LEUKOTRIENE ANTAGONIST OR A LONG ACTING β2-AGONIST IN ASTHMATIC PATIENTS POSSESSING THE GLYCINE-16 β2-ADRENOCEPTOR GENOTYPE
A COMPARISON OF SALMETEROL AND MONTELUKAST AS SECOND-LINE THERAPY IN ASTHMATIC PATIENTS NOT CONTROLLED ON INHALED CORTICOSTEROIDS
STEROID DEPENDENT ASTHMA (SDA); ITS VARIABLE PRESENTATION
COMPLIANCE WITH VITAMIN SUPPLEMENTS AND THE EFFECTIVENESS OF ADEKS® IN ADULT CYSTIC FIBROSIS PATIENTS
EXPERIENCE OF TOTALLY IMPLANTED VENOUS ACCESS DEVICES (T.I.V.A.D.S) USING RADIOLOGICAL PLACEMENT AT PAPWORTH HOSPITAL ADULT CYSTIC FIBROSIS CENTRE
THE PREVALENCE OF URINARY STRESS INCONTINENCE IN ADULT CF PATIENTS
RESULTS OF EXTENDING THE FLUSH TIME INTERVAL OF PORTACATHS IN CF PATIENTS
REVIEW OF ASSISTED PREGNANCY IN PATIENTS ATTENDING THE NOTTINGHAM ADULT CF UNIT
INTRAVENOUS PAMIDRONATE INCREASES AXIAL BONE DENSITY IN CYSTIC FIBROSIS ADULTS
PATIENT QUESTIONNAIRE SURVEY OF ADULT CF SERVICES IN NOTTINGHAM
EXTRAPLEURAL BRONCHIAL ARTERY LIGATION FOR MASSIVE HAEMOPTYSIS IN CYSTIC FIBROSIS
PSEUDOMONAS AERUGINOSA IN BRONCHIECTASIS - AGGRESSIVE TREATMENT IMPROVES LUNG FUNCTION
TOBRAMYCIN SOLUTION FOR INHALATION (TOBI) AS MAINTENANCE TREATMENT FOR BRONCHIECTASIS PATIENTS WITH PSEUDOMONAS AERUGINOSA
WHOLE SPUTUM TESTING FOR ANTIBIOTICS IN CYSTIC FIBROSIS
CLINICAL CONSEQUENCES OF A β LACTAM RESISTANT PSEUDOMONAS AERUGINOSA (Pa) STRAIN IN AN ADULT CF CLINIC
INTRAVENOUS AMINOGLYCOSIDES IN UK CYSTIC FIBROSIS CENTRES
FEV1 IS RELATED TO DURATION OF DISEASE IN CHRONIC ASTHMA
THE EFFECT OF INHLAED CORTICOSTEROIDS ON THE INTERLEUKIN-8 (IL-8) AND LEUKOTRIENE B4 (LTB 4 ) RESPONSE TO SPUTUM INDUCTION
RHINOVIRUS INFECTS THE LOWER RESPIRATORY TRACT DURING COPD EXACERBATION
EVEN THOUGH MILD ASTHMATIC SUBJECTS HAVE COMPROMISED ANTIOXIDANT STATUS AND BASAL INFLAMMATION THEY DO NOT EXHIBIT HEIGHTENED RESPONSIVENESS TO OZONE
SPUTUM INDUCTION DIFFERENTIATES UPPER AND LOWER AIRWAYS INFLAMMATION
A COMPARISON OF 2 ULTRASONIC NEBULISERS FOR SPUTUM INDUCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
SAFETY AND SUCCESS RATE OF SPUTUM INDUCTION AND REPEATABILITY OF SPUTUM CHARACTERISTICS IN PATIENTS WITH COPD
INDUCED SPUTUM CYTOSPIN QUALITY AND DIFFERENTIAL INFLAMMATORY CELL COUNTS AFTER FREEZING
INHALED BACTERIAL LIPOPOLYSACCHARIDE INCREASES EXHALED NITRIC OXIDE IN HEALTHY SUBJECTS
DOSE RELATED EFFECTS OF INHALED ENDOTOXIN IN HEALTHY HUMAN SUBJECTS
SPUTUM EOSINOPHILIA DOES NOT PREDICT CLINICAL SEVERITY IN CHRONIC ASTHMATICS
EFFECT OF ALLERGEN CHALLENGE ON AIRWAY RESPONSIVENESS TO METHACHOLINE AND LEUKOTRIENE D4
EXHALED NITRIC OXIDE IN STABLE COPD AND EXACERBATIONS
Longitudinal Change in Vital Capacity in Duchenne Muscular Dystrophy.
WHERE DO PATIENTS WITH MND DIE?
DOMICILIARY VENOUS SERUM CHLORIDE AND BICARBONATE MEASUREMENTS IN THE EVALUATION OF RESPIRATORY FUNCTION IN MOTOR NEURONE DISEASE
COUGH IN PATIENTS WITH MND
THE ROLE OF CLINICAL EXAMINATION IN IDENTIFYING CRITICAL RESPIRATORY MUSCLE WEAKNESS IN PATIENTS WITH MND
DIAPHRAGM FATIGUE IN WEANING PATIENTS ON THE ICU
A NEW METHOD TO QUANTIFY RESPIRATORY MUSCLE ENDURANCE(RME)
COMPARISON OF A YAN-STYLE COUGH CHALLENGE WITH AN ESTABLISHED DOSIMETER METHOD
COMPARISON OF AIRWAY AND SKIN RESPONSES TO INHALED PAVA AND CAPSAICIN
FEMALE GENDER AND ENHANCED CITRIC ACIDINDUCED COUGH RESPONSE
Does subjective cough severity relate to objective measures in asthma?
A SYSTEMATIC EVALUATION OF CHRONIC COUGH
PROLONGED INHIBITION OF THE COUGH REFLEX BY DEXTROMETHORPHAN: COMPARISON WITH ITS METABOLITE DEXTRORPHAN
ASSESSMENT OF A NEW LOW-COST PORTABLE SPIROMETER (VMPLUS, CLEMENT CLARKE) FOR USE IN CHILDREN
SIX YEAR RESULTS OF A ROUTINE 24 HOUR TRACHEAL/OESOPHAGEAL pH MONITORING SERVICE
ARTERIALISED CAPILLARY BLOOD GAS ANALYSIS REMAINS AN UNDERUSED TECHNIQUE
COMPARISON OF FORCED SPIROMETRY RESULTS BETWEEN SPIROMETERS FROM DIFFERENT MANUFACTURERS
A NATIONAL SURVEY OF SPIROMETRY USE IN PRIMARY CARE
DO WE NEED NEW REFERENCE RANGES FOR LUNG FUNCTION MEASURES IN THE ELDERLY?
ARTERIALISED EARLOBE BLOOD GASES: USE FOR LTOT PRESCRIPTION
DOES IT MATTER WHICH TYPE OF SPIROMETER IS USED TO MEASURE FEV1, FVC AND VC?.
THE INFLUENCE OF DEVICE ON THE MEASUREMENT OF SPIROMETRIC INDICES
CAN THE DISTANCE WALKED DURING THE SHUTTLE WALKING TEST PREDICT PEAK OXYGEN UPTAKE?
PATHOGENIC α1-ANTITRYPSIN POLYMERS ARE FORMED BY REACTIVE LOOP-β-SHEET A LINKAGE
PULMONARY FIBROBLASTS ARE A SOURCE AND SITE OF ACTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF).
THE SELECTIVE UPREGULATION OF INTERLEUKIN 8 (IL-8) FROM HYPOXIC HUMAN MACROPHAGES - A POTENTIAL ROLE IN THE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
CHARACTERIZATION OF A NEW MONOCLONAL ANTIBODY (MMC4) RAISED AGAINST RAT ALVEOLAR EPITHELIAL TYPE II CELLS; MOLECULAR WEIGHT DETERMINATION
STIMULUS-SPECIFIC REDUCTION OF NEUTROPHIL INTERLEUKIN-8 RELEASE IN ACUTE RESPIRATORY DISTRESS SYNDROME
CHARACTERISATION OF THE INTERACTION OF MAST CELL TRYPTASE WITH PROTEASE-ACTIVATED RECEPTOR-2 (PAR-2) ON HUMAN LUNG FIBROBLASTS
INDUCIBLE HAEM OXYGENASE IS PRESENT IN BRONCHOAL VEOLAR LAVAGE (BAL) FLUID FROM PATIENTS WITH ARDS: ASSOCIATIONS WITH OXIDATIVE STRESS AND FREE IRON LEVELS
LOCALISATION OF γ-GLUTAMYLCYSTEINE SYNTHETASE mRNA EXPRESSION IN LUNGS OF SMOKERS AND PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
LPS-MEDIATED INDUCTION OF IL-8 IS INHIBITED BY THIOL ANTIOXIDANTS AT THE TRANSCRIPTIONAL LEVEL IN THP-I CELLS: ROLE IN CHEMOTAXIS.
THE INTERACTION OF M, S, Z, LATENT AND CLEAVED PLASMA ALPHA-1-ANTITRYPSIN WITH HUMAN NEUTROPHIL DEFENSIN-1
DNA REPAIR ENZYMES IN THE BRONCHIAL EPITHELIUM
MATRIX METALLOPROTEINASE ACTIVITY IN MALIGNANT MESOTHELIOMA AND BENIGN PLEURA
INCREASED CHALKLEY MICROVESSEL COUNTS ARE RELATED TO PLATELET COUNT AND CONVEY POOR PROGNOSIS IN MALIGNANT MESOTHELIOMA
ADENOSINE DEAMINASE IS A USEFUL MARKER IN THE DIFFERENTIAL DIAGNOSIS OF TUBERCULOUS AND MALIGNANT PLEURAL EFFUSIONS IN ROUTINE CLINICAL PRACTICE IN AREAS OF LOW TB PREVALENCE
PROGNOSTIC FACTORS FOR MALIGNANT MESOTHELIOMA IN LEICESTER: VALIDATION OF EORTC AND CALGB SCORES
OCCUPATION AND MESOTHELIOMA IN YOUNG MEN: A PRELIMINARY REPORT
MMP-9 AND THE EPIDERMAL GROWTH FACTOR SIGNAL PATHWAY IN NON-SMALL CELL LUNG CANCER
EXPRESSION AND PROGNOSTIC INFLUENCE OF MMP-2, MMP-9 AND TIMP-2 IN NON-SMALL CELL LUNG CANCER
STUDY OF LUNG CANCER CELLS BY FOURIER TRANSFORM INFRARED SPECTROSCOPY
UTILITY OF TRANS-CARINAL NEEDLE ASPIRATION (TCNA) IN DETECTION OF SUBCARINAL MALIGNANCY
IS THE COLLECTION OF CYTOLOGY SPECIMENS A USEFUL ADJUNCT TO BIOPSY FOR POSSIBLE AND DEFINITE TUMOURS VISIBLE AT BRONCHOSCOPY?
BRONCHIAL WASHINGS - WHEN SHOULD WE DO THEM?
A TRIAL OF SPUTUM INDUCTION IN THE DIAGNOSIS OF LUNG CANCER
MEDICAL THORACOSCOPY IN THE UK, A SURVEY OF RESPIRATORY PHYSICIANS
A COMPARISON OF ALFENTANYL AND MIDAZOLAM AS PREMEDICATION FOR FLEXIBLE BRONCHOSCOPY
SYSTEMIC ABSORPTION OF COCAINE DURING FIBRE-OPTIC BRONCHOSCOPY